Viewing Study NCT05325632


Ignite Creation Date: 2025-12-24 @ 9:36 PM
Ignite Modification Date: 2026-01-05 @ 5:40 PM
Study NCT ID: NCT05325632
Status: RECRUITING
Last Update Posted: 2025-12-15
First Post: 2022-03-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module